CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.
Leuci V, Casucci GM, Grignani G, Rotolo R, Rossotti U, Vigna E, Gammaitoni L, Mesiano G, Fiorino E, Donini C, Pisacane A, Ambrosio LD, Pignochino Y, Aglietta M, Bondanza A, Sangiolo D.
Leuci V, et al. Among authors: casucci gm.
Oncoimmunology. 2018 Feb 15;7(5):e1423167. doi: 10.1080/2162402X.2017.1423167. eCollection 2018.
Oncoimmunology. 2018.
PMID: 29721373
Free PMC article.